Generic Cos. Pan 'Irrelevant' Doc Demands In Price-Fix Case
Numerous generic-drug makers entangled in a vast price-fixing suit in Pennsylvania federal court are slamming a special master's plan for discovery, claiming that his recommendation would force them to produce millions...To view the full article, register now.
Already a subscriber? Click here to view full article